HIV Infections Clinical Trials in Columbus, Ohio

4 studies are recruiting for hiv infections in Columbus, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

   The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the United States. The study will characterize how PrEP is initiated, used, and discontinued in routine …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ohio State University Infectious Diseases Clinical Trials Unit, Columbus, Ohio

   Locations

   38 in total

   Run by

   Gilead Sciences

   See if you can join NCT07473778 on ClinicalTrials.gov

2. Positive Peers Intervention Clinical Trial

   The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are ass…

   Stage

   Not phased

   Ages

   13 to 34

   Site

   Equitas Health, Columbus, Ohio

   Locations

   7 in total

   Run by

   MetroHealth Medical Center

   See if you can join NCT06388109 on ClinicalTrials.gov

3. A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

   This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).

   Stage

   Phase 3

   Ages

   12 and older

   Site

   GSK Investigational Site, Columbus, Ohio

   Locations

   88 in total

   Run by

   ViiV Healthcare

   See if you can join NCT07650916 on ClinicalTrials.gov

4. Screen Smart: Using Digital Health to Improve HIV Screening and Prevention

   The goal of this interrupted time series quasi-experimental design study is to implement universal opt- out HIV testing and linkage to HIV preventive care in 15-21 year old adolescents visiting the pediatric emergency department (ED). The main question[s] it aims to answer are: 1. What is the uptak…

   Stage

   Not phased

   Ages

   15 to 21

   Site

   Nationwide Children's Hospital, Columbus, Ohio

   Locations

   4 in total

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT06003192 on ClinicalTrials.gov